FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2032936189> ?p ?o ?g. }

• W2032936189 endingPage "127" @default.
• W2032936189 startingPage "120" @default.
• W2032936189 abstract "The launch of imatinib has turned chronic myeloid leukaemia (CML) into a chronic illness due to the dramatic improvement in survival. Several recent studies have demonstrated that poor adherence to imatinib may hamper the therapeutic outcomes and result in increased medical expenditures, whilst research on exploring the reasons for non-adherence to imatinib is still limited.This study aimed to explore the experience of patients as they journey through their CML treatments and associated imatinib utilisation in order to understand the perceptions, attitudes and concerns that may influence adherence to imatinib treatment.This study was conducted at oncology outpatient clinics in a medical centre in southern Taiwan.CML patients who regularly attended the oncology outpatient clinics to receive imatinib treatment from October 2011 to March 2012 were invited to participate in the study. Semi-structured face-to-face interviews were used to explore patients' experiences and views of their treatment, their current CML status and CML-related health conditions, their concerns about imatinib treatment and imatinib-taking behaviours. Patient interviews were recorded, transcribed verbatim and thematically analysed using the constant comparison approach.Themes related to patients' views of the disease and health conditions, worries and concerns influencing imatinib utilisation behaviours are reported.Forty-two CML patients participated in the interviews. The emerging themes included: acceptance of current disease and health status, misconceptions about disease progression, factors associated with adherence to imatinib, concerns and management of adverse drug effects. Participants regarded CML as a chronic disease but had misconceptions about disease progression, therapeutic monitoring, resistance to imatinib and symptoms of side effects. Participants were generally adherent to imatinib and favoured long-term prescriptions to avoid regular outpatient visits for medication refills. Experiencing adverse effect was the main reason influencing adherence and led to polypharmacy. Most participants altered medicine-taking behaviours to maintain long-term use of imatinib.Taiwanese CML patients are adherent to imatinib but report changing their medication-taking behaviour due to adverse drug effects and associated polypharmacy. Patients' misconceptions of the disease and medication suggests that it is necessary to improve communication between patients and healthcare professionals. Routinely providing updated information as part of the patient counselling process should be considered as a means of improving this communication." @default.
• W2032936189 created "2016-06-24" @default.
• W2032936189 creator A5014763436 @default.
• W2032936189 creator A5044069116 @default.
• W2032936189 creator A5071313235 @default.
• W2032936189 creator A5083177735 @default.
• W2032936189 date "2013-10-24" @default.
• W2032936189 modified "2023-10-18" @default.
• W2032936189 title "Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients" @default.
• W2032936189 cites W121414984 @default.
• W2032936189 cites W1525863247 @default.
• W2032936189 cites W1544133109 @default.
• W2032936189 cites W1606656369 @default.
• W2032936189 cites W1905936368 @default.
• W2032936189 cites W1969330689 @default.
• W2032936189 cites W1973649703 @default.
• W2032936189 cites W2005680753 @default.
• W2032936189 cites W2010273779 @default.
• W2032936189 cites W2024127533 @default.
• W2032936189 cites W2033978323 @default.
• W2032936189 cites W2048809946 @default.
• W2032936189 cites W2053780376 @default.
• W2032936189 cites W2053873258 @default.
• W2032936189 cites W2062366392 @default.
• W2032936189 cites W2086892782 @default.
• W2032936189 cites W2095068664 @default.
• W2032936189 cites W2095215447 @default.
• W2032936189 cites W2109238714 @default.
• W2032936189 cites W2112190338 @default.
• W2032936189 cites W2134839096 @default.
• W2032936189 cites W2137665561 @default.
• W2032936189 cites W2139062201 @default.
• W2032936189 cites W2140201003 @default.
• W2032936189 cites W2140737508 @default.
• W2032936189 cites W2145355470 @default.
• W2032936189 cites W2146194560 @default.
• W2032936189 cites W2147854328 @default.
• W2032936189 cites W2147982456 @default.
• W2032936189 cites W2166270808 @default.
• W2032936189 cites W2166754635 @default.
• W2032936189 cites W2334366154 @default.
• W2032936189 cites W2397791882 @default.
• W2032936189 cites W3027130291 @default.
• W2032936189 doi "https://doi.org/10.1007/s11096-013-9867-8" @default.
• W2032936189 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3890041" @default.
• W2032936189 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24154825" @default.
• W2032936189 hasPublicationYear "2013" @default.
• W2032936189 type Work @default.
• W2032936189 sameAs 2032936189 @default.
• W2032936189 citedByCount "30" @default.
• W2032936189 countsByYear W20329361892013 @default.
• W2032936189 countsByYear W20329361892014 @default.
• W2032936189 countsByYear W20329361892015 @default.
• W2032936189 countsByYear W20329361892016 @default.
• W2032936189 countsByYear W20329361892017 @default.
• W2032936189 countsByYear W20329361892018 @default.
• W2032936189 countsByYear W20329361892019 @default.
• W2032936189 countsByYear W20329361892020 @default.
• W2032936189 countsByYear W20329361892021 @default.
• W2032936189 countsByYear W20329361892022 @default.
• W2032936189 countsByYear W20329361892023 @default.
• W2032936189 crossrefType "journal-article" @default.
• W2032936189 hasAuthorship W2032936189A5014763436 @default.
• W2032936189 hasAuthorship W2032936189A5044069116 @default.
• W2032936189 hasAuthorship W2032936189A5071313235 @default.
• W2032936189 hasAuthorship W2032936189A5083177735 @default.
• W2032936189 hasBestOaLocation W20329361891 @default.
• W2032936189 hasConcept C104863432 @default.
• W2032936189 hasConcept C126322002 @default.
• W2032936189 hasConcept C160735492 @default.
• W2032936189 hasConcept C162324750 @default.
• W2032936189 hasConcept C197934379 @default.
• W2032936189 hasConcept C2777583451 @default.
• W2032936189 hasConcept C2778729363 @default.
• W2032936189 hasConcept C2779134260 @default.
• W2032936189 hasConcept C2993416501 @default.
• W2032936189 hasConcept C3019892230 @default.
• W2032936189 hasConcept C50522688 @default.
• W2032936189 hasConcept C512399662 @default.
• W2032936189 hasConcept C71924100 @default.
• W2032936189 hasConceptScore W2032936189C104863432 @default.
• W2032936189 hasConceptScore W2032936189C126322002 @default.
• W2032936189 hasConceptScore W2032936189C160735492 @default.
• W2032936189 hasConceptScore W2032936189C162324750 @default.
• W2032936189 hasConceptScore W2032936189C197934379 @default.
• W2032936189 hasConceptScore W2032936189C2777583451 @default.
• W2032936189 hasConceptScore W2032936189C2778729363 @default.
• W2032936189 hasConceptScore W2032936189C2779134260 @default.
• W2032936189 hasConceptScore W2032936189C2993416501 @default.
• W2032936189 hasConceptScore W2032936189C3019892230 @default.
• W2032936189 hasConceptScore W2032936189C50522688 @default.
• W2032936189 hasConceptScore W2032936189C512399662 @default.
• W2032936189 hasConceptScore W2032936189C71924100 @default.
• W2032936189 hasIssue "1" @default.
• W2032936189 hasLocation W20329361891 @default.
• W2032936189 hasLocation W20329361892 @default.
• W2032936189 hasLocation W20329361893 @default.
• W2032936189 hasLocation W20329361894 @default.

• next